Inspire Pharmaceuticals, Inc. (ISPH) – Bull of the Day - StraightStocks

Sign Up | Log In | What is SocialPicks?

Inspire Pharmaceuticals, Inc. (ISPH) – Bull of the Day
Nov 09, 2009 05:00 AM UTC

StraightStocks

Return	Risk
-6.57%	MID

Analyst

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
ISPH	n/a

Via StraightStocks:

Inspire Pharmaceuticals, Inc. (ISPH)

is a specialty pharmaceutical company focused on the development and commercialization of

treatments for respiratory and ophthalmologic disorders.

Currently, the company has three products on the market and a robust pipeline. We see strong

top line growth from 2009 and beyond. Inspire just reported positive phase III data of

Denufosol for CF. The company has a strong collaborative alliance with Allergan

Pharmaceuticals for key products that treat dry eyes and allergic conjunctivitis.

Current price is attractive. We maintain our Outperform rating on shares of Inspire with a

price target of $7.00.

Zacks Investment Research

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.